We checked the expression of SMYD2 and p53 in parallel in the urethane lung cancer mouse model at different time periods of carcinoma development as well as after the treatment with IONPs loaded with the potent SMYD2 inhibitor LLY-507. The gene discussed is TP53; the disease is carcinoma.